Cervicovaginal Safety of the Formulated, Biguanide-Based Human Immunodeficiency Virus Type 1 (HIV-1) Inhibitor NB325 in a Murine Model

by Karissa Lozenski, Tina Kish-Catalone, Vanessa Pirrone, Robert F. Rando, Mohamed Labib, Brian Wigdahl, Fred C. Krebs
Published 2011-01-01